Kyowa Hakko Kirin
Also known as: Fujifilm Kyowa Kirin Biologics Co., Ltd. | Jeil-Kirin Pharmaceutical Inc. | Kyowa Hakko Kirin China Pharmaceutical Co., LTD. | Kyowa Hakko Kirin China Pharmaceutical Co.,LTD. | Kyowa Hakko Kirin Co. | Kyowa Hakko Kirin Co., Ltd | Kyowa Hakko Kirin Korea Co., Ltd. | Kyowa Hakko Kirin Pharma, Inc. | Kyowa Hakko Kirin UK | Kyowa Hakko Kirin UK, Ltd. | Kyowa Kirin China Pharmaceutical Co., Ltd. | Kyowa Kirin Co., Ltd. | Kyowa Kirin, Inc. | Kyowa Kirin Pharmaceutical Development Ltd
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2008Last known activity
Jan 23, 2026
Timeline
2000s
- Oct 1, 2008
Kyowa Hakko Kirin— Founded
- Oct 1, 2008
Kirin— Acquired
- Oct 1, 2008
Kyowa Hakko Kogyo— Acquired
2010s
- Jan 1, 2011
ProStraken— Acquired
- Jan 1, 2014
Archimedes Pharma Ltd— Acquired
Drugs by trial phase (119 distinct, 242 trials)
Phase 4 (5 own, 6 via acquisition)
Phase 3 (15 own, 5 via acquisition)
Phase 2 (42 own, 3 via acquisition)
Phase 1 (35 own, 0 via acquisition)
Other trials (0 own, 8 via acquisition)
Indications
Studied for
- Abdominal Pain
- Adenocarcinoma
- Alzheimer Disease
- Anemia
- Anemia, Aplastic
- Antithrombin III Deficiency
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Asthma
- Autoimmune Diseases
- Bone Marrow Diseases
- Breakthrough Pain
- Breast Neoplasms
- Cancer Pain
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colitis
- Colitis, Ulcerative
- Colonic Diseases
- Colorectal Neoplasms
- Constipation
- Dermatitis
- Dermatitis, Atopic
- Dermatitis, Exfoliative
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Digestive System Diseases
- Disseminated Intravascular Coagulation
- Eczema
- Fallopian Tube Neoplasms
- Familial Hypophosphatemic Rickets
- Febrile Neutropenia
- Gastrointestinal Diseases
- Glomerulosclerosis, Focal Segmental
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypercalcemia
- Hyperparathyroidism
- Hyperparathyroidism, Primary
- Hyperparathyroidism, Secondary
- Hyperphosphatemia
- Hypophosphatemia
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Kidney Diseases
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, T-Cell
- Liver Diseases
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, T-Cell, Peripheral
- Macular Degeneration
- Melanoma
- Mesothelioma
- Mouth Neoplasms
- Movement Disorders
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Connective Tissue
- Neoplasms, Plasma Cell
- Neuralgia
- Neuralgia, Postherpetic
- Neutropenia
- Nevus
- Nevus, Sebaceous of Jadassohn
- Obesity
- Osteomalacia
- Ovarian Neoplasms
- Paraparesis, Tropical Spastic
- Parasomnias
- Parathyroid Neoplasms
- Parkinson Disease
- Peritoneal Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pre-Eclampsia
- Preleukemia
- Psoriasis
- Psychomotor Agitation
- Pulmonary Eosinophilia
Subsidiaries (4 direct, 4 total across the full acquisition tree)
Recent trials (50)
- NCT03775187CollaboratorN/A—
- NCT07192471Lead sponsorPhase 1Jan 23, 2026
- NCT06823947OfficialPhase 1Apr 3, 2025
- NCT06823947Lead sponsorPhase 1Apr 3, 2025
- NCT06926491OfficialPhase 3Dec 1, 2024
- NCT06926491Lead sponsorPhase 3Dec 1, 2024
- NCT06812104OfficialPhase 1Oct 10, 2024
- NCT06812104Lead sponsorPhase 1Oct 10, 2024
- NCT06525636Lead sponsorPhase 1/Phase 2Oct 9, 2024
- NCT06525636OfficialPhase 1/Phase 2Oct 9, 2024
- NCT05996185CollaboratorPhase 2Jan 31, 2024
- NCT06266299Lead sponsorPhase 1Jan 25, 2024
- NCT06235281CollaboratorEarly Phase 1Jan 18, 2024
- NCT06116916Study directorPhase 2Nov 30, 2023
- NCT06116916Lead sponsorPhase 2Nov 30, 2023
Details
- Founded
- Tokyo, JP Oct 1, 2008
- Last known activity
- Jan 23, 2026